Lipids & metabolic liver disease

Impact of Thyroid Function on the Prevalence and Mortality of Metabolic Dysfunction-Associated Fatty Liver Disease

J Clin Endocrinol MetabPublished Cross-sectional and cohort analysis of NHANES III data

Authors' conclusion

Low thyroid function is independent risk factor of MAFLD and is associated with increased risk for all-cause and cardiovascular mortality in the MAFLD population. Reevaluation of TSH reference range should be considered.

Study context

Population
Participants of the Third National Health and Nutrition Examination Survey (NHANES III); MAFLD diagnosed by the new definition
Participants
10,666 participants
Exposure
Thyroid function categories by thyroid-stimulating hormone (TSH)
Outcome
Prevalence and mortality of MAFLD
Methodological detailsmultivariate logistic and Cox regression
  • Multivariate logistic and Cox regression

Main finding

As reported in the abstract

MAFLD prevalence and all-cause and cardiovascular mortality
Low thyroid function · MAFLD; independent association
OR 1.27
SCH · all-cause mortality, total population
HR 1.23
SCH · cardiovascular mortality, total population
HR 1.65
SCH · all-cause mortality, MAFLD population
HR 1.32
SCH · cardiovascular mortality, MAFLD population
HR 1.99

Observational data: associations, not effects.

Original publication

Impact of Thyroid Function on the Prevalence and Mortality of Metabolic Dysfunction-Associated Fatty Liver Disease. J Clin Endocrinol Metab. Published 13 January 2023. doi:10.1210/clinem/dgad016

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.